Summary
Global Market Direct’s pharmaceuticals report, “UCLA's Jonsson Comprehensive Cancer Center – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). It also gives a complete picture of the institute’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by UCLA's Jonsson Comprehensive Cancer Center.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of UCLA's Jonsson Comprehensive Cancer Center with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of UCLA's Jonsson Comprehensive Cancer Center’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in UCLA's Jonsson Comprehensive Cancer Center’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate UCLA's Jonsson Comprehensive Cancer Center’s position with total access to a detailed intelligence on its therapeutic products development.
- Assess the growth potential of UCLA's Jonsson Comprehensive Cancer Center in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with UCLA's Jonsson Comprehensive Cancer Center.
- Avoid Intellectual Property Rights related issues.
- Undertake deals with an understanding of the mergers and partnerships that have shaped the sector.
Global Market Direct’s pharmaceuticals report, “UCLA's Jonsson Comprehensive Cancer Center – Developmental Therapeutics Review – Q4 2010” provides data on the institute’s research and development focus. The report includes information on therapeutics under development, complete with latest updates, and features on discontinued projects (if applicable). It also gives a complete picture of the institute’s future therapy areas of focus.
This report is built using data and information sourced from Global Markets Direct’s proprietary databases, primary and secondary research using institute’s website, and featured press releases, both from institute and industry-specific third party sources, put together with in-house analysis, by Global Markets Direct’s team of industry experts.
Scope
- Review of therapeutics under development by UCLA's Jonsson Comprehensive Cancer Center.
- Overview of products under development across various therapy areas.
- Coverage of therapeutic molecules in various stages of drug development, including the combination treatment modalities, for the pharmaceutical markets across the globe.
- Product profiles for late stage and clinical stage products of UCLA's Jonsson Comprehensive Cancer Center with complete description of the product’s developmental history, mechanism of action, clinical trials, major milestones and others.
- Recent updates of UCLA's Jonsson Comprehensive Cancer Center’s therapeutic products in the last quarter.
- Latest news and deals relating to the products.
Reasons to buy
- Identify new drug targets and therapeutic classes in UCLA's Jonsson Comprehensive Cancer Center’s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas.
- Exploit in-licensing opportunities by identifying opportunities to fill portfolio gaps.
- Evaluate UCLA's Jonsson Comprehensive Cancer Center’s position with total access to a detailed intelligence on its therapeutic products development.
- Assess the growth potential of UCLA's Jonsson Comprehensive Cancer Center in its therapy areas of focus.
- Exploit collaboration and partnership opportunities with UCLA's Jonsson Comprehensive Cancer Center.
- Avoid Intellectual Property Rights related issues.
- Undertake deals with an understanding of the mergers and partnerships that have shaped the sector.
1 TABLE OF CONTENTS
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - RESEARCH AND DEVELOPMENT OVERVIEW
3.1 Key Therapeutic Areas
4 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS REVIEW
4.1 Products by Stage of Development
4.2 Products - Monotherapy
4.3 Products - Combination Treatment Modalities
5 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS GLANCE
5.1 UCLA's Jonsson Comprehensive Cancer Center - Phase III Products
5.2 UCLA's Jonsson Comprehensive Cancer Center - Phase II Products
5.3 UCLA's Jonsson Comprehensive Cancer Center - Phase I Products
5.4 UCLA's Jonsson Comprehensive Cancer Center - Pre-Clinical and Discovery Products
6 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - DRUG PROFILES
6.1 Product 1 - Product Profile
6.1.1 Product Description
6.1.2 Mechanism of Action
6.1.3 R&D Progress
7 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS ANALYSIS
7.1 UCLA's Jonsson Comprehensive Cancer Center Products by Therapeutic Class
7.2 UCLA's Jonsson Comprehensive Cancer Center Products by Target
7.3 UCLA's Jonsson Comprehensive Cancer Center by Route of Administration
7.4 UCLA's Jonsson Comprehensive Cancer Center Products by Molecule Type
8 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - RECENT PRODUCT UPDATES
9 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - FEATURED NEWS
10 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - LOCATIONS
11 APPENDIX
11.1 Global Markets Direct Research Methodology
11.2 Coverage
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Expert Panels
11.7 Contact Us
11.8 Disclaimer
LIST OF TABLES
Table 1: UCLA's Jonsson Comprehensive Cancer Center - Key Therapeutic Areas
Table 2: UCLA's Jonsson Comprehensive Cancer Center - Products by Stage of Development,
Table 3: UCLA's Jonsson Comprehensive Cancer Center - Monotherapy Products under Investigation,
Table 4: UCLA's Jonsson Comprehensive Cancer Center - Combination Treatment Modalities under Investigation,
Table 5: UCLA's Jonsson Comprehensive Cancer Center - Phase III Products,
Table 6: UCLA's Jonsson Comprehensive Cancer Center - Phase II Products,
Table 7: UCLA's Jonsson Comprehensive Cancer Center - Phase I Products,
Table 8: UCLA's Jonsson Comprehensive Cancer Center - Pre-Clinical and Discovery Products,
Table 9: UCLA's Jonsson Comprehensive Cancer Center - Products By Therapeutic Class
Table 10: UCLA's Jonsson Comprehensive Cancer Center - Products By Target
Table 11: UCLA's Jonsson Comprehensive Cancer Center - Products By Route of Administration
Table 12: UCLA's Jonsson Comprehensive Cancer Center - Products By Molecule Type
Table 13: UCLA's Jonsson Comprehensive Cancer Center - Recent Product Updates
LIST OF FIGURES
Figure 1: UCLA's Jonsson Comprehensive Cancer Center - Research and Development Overview
Figure 2: UCLA's Jonsson Comprehensive Cancer Center - Products by Stage of Development,
Figure 3: UCLA's Jonsson Comprehensive Cancer Center - Monotherapy Products,
Figure 4: UCLA's Jonsson Comprehensive Cancer Center - Combination Treatment Modalities,
Figure 5: UCLA's Jonsson Comprehensive Cancer Center - Products By Therapeutic Class and Stage of Development
Figure 6: UCLA's Jonsson Comprehensive Cancer Center - Products By Therapeutic Class
Figure 7: UCLA's Jonsson Comprehensive Cancer Center - Products By Target and Stage of Development
Figure 8: UCLA's Jonsson Comprehensive Cancer Center - Products By Target
Figure 9: UCLA's Jonsson Comprehensive Cancer Center - Products By Route of Administration and Stage of Development
Figure 10: UCLA's Jonsson Comprehensive Cancer Center - Products By Route of Administration
Figure 11: UCLA's Jonsson Comprehensive Cancer Center - Products By Molecule Type and Stage of Development
Figure 12: UCLA's Jonsson Comprehensive Cancer Center - Products By Molecule Type
COMPANIES MENTIONED
UCLA's Jonsson Comprehensive Cancer Center
1.1 List of Tables
1.2 list of Figures
2 INTRODUCTION
3 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - RESEARCH AND DEVELOPMENT OVERVIEW
3.1 Key Therapeutic Areas
4 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS REVIEW
4.1 Products by Stage of Development
4.2 Products - Monotherapy
4.3 Products - Combination Treatment Modalities
5 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS GLANCE
5.1 UCLA's Jonsson Comprehensive Cancer Center - Phase III Products
5.2 UCLA's Jonsson Comprehensive Cancer Center - Phase II Products
5.3 UCLA's Jonsson Comprehensive Cancer Center - Phase I Products
5.4 UCLA's Jonsson Comprehensive Cancer Center - Pre-Clinical and Discovery Products
6 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - DRUG PROFILES
6.1 Product 1 - Product Profile
6.1.1 Product Description
6.1.2 Mechanism of Action
6.1.3 R&D Progress
7 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - INVESTIGATIONAL PRODUCTS ANALYSIS
7.1 UCLA's Jonsson Comprehensive Cancer Center Products by Therapeutic Class
7.2 UCLA's Jonsson Comprehensive Cancer Center Products by Target
7.3 UCLA's Jonsson Comprehensive Cancer Center by Route of Administration
7.4 UCLA's Jonsson Comprehensive Cancer Center Products by Molecule Type
8 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - RECENT PRODUCT UPDATES
9 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - FEATURED NEWS
10 UCLA'S JONSSON COMPREHENSIVE CANCER CENTER - LOCATIONS
11 APPENDIX
11.1 Global Markets Direct Research Methodology
11.2 Coverage
11.3 Secondary Research
11.4 Primary Research
11.5 Models
11.6 Expert Panels
11.7 Contact Us
11.8 Disclaimer
LIST OF TABLES
Table 1: UCLA's Jonsson Comprehensive Cancer Center - Key Therapeutic Areas
Table 2: UCLA's Jonsson Comprehensive Cancer Center - Products by Stage of Development,
Table 3: UCLA's Jonsson Comprehensive Cancer Center - Monotherapy Products under Investigation,
Table 4: UCLA's Jonsson Comprehensive Cancer Center - Combination Treatment Modalities under Investigation,
Table 5: UCLA's Jonsson Comprehensive Cancer Center - Phase III Products,
Table 6: UCLA's Jonsson Comprehensive Cancer Center - Phase II Products,
Table 7: UCLA's Jonsson Comprehensive Cancer Center - Phase I Products,
Table 8: UCLA's Jonsson Comprehensive Cancer Center - Pre-Clinical and Discovery Products,
Table 9: UCLA's Jonsson Comprehensive Cancer Center - Products By Therapeutic Class
Table 10: UCLA's Jonsson Comprehensive Cancer Center - Products By Target
Table 11: UCLA's Jonsson Comprehensive Cancer Center - Products By Route of Administration
Table 12: UCLA's Jonsson Comprehensive Cancer Center - Products By Molecule Type
Table 13: UCLA's Jonsson Comprehensive Cancer Center - Recent Product Updates
LIST OF FIGURES
Figure 1: UCLA's Jonsson Comprehensive Cancer Center - Research and Development Overview
Figure 2: UCLA's Jonsson Comprehensive Cancer Center - Products by Stage of Development,
Figure 3: UCLA's Jonsson Comprehensive Cancer Center - Monotherapy Products,
Figure 4: UCLA's Jonsson Comprehensive Cancer Center - Combination Treatment Modalities,
Figure 5: UCLA's Jonsson Comprehensive Cancer Center - Products By Therapeutic Class and Stage of Development
Figure 6: UCLA's Jonsson Comprehensive Cancer Center - Products By Therapeutic Class
Figure 7: UCLA's Jonsson Comprehensive Cancer Center - Products By Target and Stage of Development
Figure 8: UCLA's Jonsson Comprehensive Cancer Center - Products By Target
Figure 9: UCLA's Jonsson Comprehensive Cancer Center - Products By Route of Administration and Stage of Development
Figure 10: UCLA's Jonsson Comprehensive Cancer Center - Products By Route of Administration
Figure 11: UCLA's Jonsson Comprehensive Cancer Center - Products By Molecule Type and Stage of Development
Figure 12: UCLA's Jonsson Comprehensive Cancer Center - Products By Molecule Type
COMPANIES MENTIONED
UCLA's Jonsson Comprehensive Cancer Center
